Suppr超能文献

肝硬化患者心钠素的清除。肝功能衰竭的作用。

Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure.

作者信息

Moreau R, Pussard E, Brenard R, Gaudin C, Berdeaux A, Lebrec D

机构信息

Laboratoire d'Hémodynamique Splanchnique, Hôpital Beaujon, Clichy, France.

出版信息

J Hepatol. 1991 Nov;13(3):351-7. doi: 10.1016/0168-8278(91)90080-u.

Abstract

In non-cirrhotic patients, splanchnic, renal and pulmonary vascular beds are involved in the plasma clearance for atrial natriuretic peptide (ANP). In patients with cirrhosis, endogenous plasma ANP clearance by these vascular beds has not been systematically studied. In addition, the influence of the severity of liver failure on plasma ANP clearance is not known. Thus, in this study we determined plasma ANP clearance by splanchnic, renal and pulmonary circulations using both arteriovenous differences in plasma ANP concentrations and organ plasma flow in 11 patients with cirrhosis. The role of forearm circulation in plasma ANP extraction was also studied. Splanchnic plasma ANP extraction was 29 +/- 7% (mean +/- S.E.) and splanchnic plasma ANP clearance was 404 +/- 130 ml/min (n = 7). Renal plasma ANP extraction and clearance were 32 +/- 8% and 191 +/- 57 ml/min, respectively. Forearm plasma ANP extraction was 11 +/- 4%. Pulmonary plasma ANP extraction and clearance were 8 +/- 5% and 312 +/- 272 ml/min, respectively. A significant negative correlation was found between logarithm of serum bilirubin concentration, on one hand, and splanchnic and forearm plasma ANP extraction, on the other. A significant negative correlation was found between Pugh's score, on one hand, and renal plasma ANP extraction and clearance, on the other. No significant correlation was found between the severity of liver failure and pulmonary plasma ANP extraction and clearance. As a result, we conclude that in cirrhotic patients splanchnic, renal, forearm and pulmonary vascular beds are involved in plasma ANP extraction and clearance. Plasma ANP extraction and/or clearance may be attenuated in the splanchnic, renal and forearm circulations due to liver failure.

摘要

在非肝硬化患者中,内脏、肾脏和肺血管床参与心房利钠肽(ANP)的血浆清除。在肝硬化患者中,这些血管床对内源性血浆ANP的清除尚未进行系统研究。此外,肝功能衰竭的严重程度对血浆ANP清除的影响尚不清楚。因此,在本研究中,我们通过测量11例肝硬化患者血浆ANP浓度的动静脉差值和器官血浆流量,来测定内脏、肾脏和肺循环对血浆ANP的清除情况。我们还研究了前臂循环在血浆ANP摄取中的作用。内脏血浆ANP摄取率为29±7%(平均值±标准误),内脏血浆ANP清除率为404±130 ml/min(n = 7)。肾脏血浆ANP摄取率和清除率分别为32±8%和191±57 ml/min。前臂血浆ANP摄取率为11±4%。肺血浆ANP摄取率和清除率分别为8±5%和312±272 ml/min。一方面,血清胆红素浓度的对数与另一方面的内脏和前臂血浆ANP摄取之间存在显著负相关。一方面,Pugh评分与另一方面的肾脏血浆ANP摄取和清除之间存在显著负相关。肝功能衰竭的严重程度与肺血浆ANP摄取和清除之间未发现显著相关性。因此,我们得出结论,在肝硬化患者中,内脏、肾脏、前臂和肺血管床参与血浆ANP的摄取和清除。由于肝功能衰竭,内脏、肾脏和前臂循环中的血浆ANP摄取和/或清除可能会减弱。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验